Attached files

file filename
10-Q - FORM 10-Q - NewGen BioPharma Corp.2015july31-grwd_10q.htm
EX-31.2 - EX-31.2 - NewGen BioPharma Corp.ex-31_2.htm
EX-31.1 - EX-31.1 - NewGen BioPharma Corp.ex-31_1.htm
EX-32.2 - EX-32.2 - NewGen BioPharma Corp.ex-32_2.htm
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of Greenwind NRG Inc. (the “Company”) for the period ended July 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
 
1.           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
 

 
Date:  September 10, 2015
 
 
 
 
 
By:
 /s/ Jerwin Alfiler
 
 
 Name:
Jerwin Alfiler
 
 
 Title:
President, Secretary, Treasurer and Director (Principal Executive Officer)